Effects of Vasopressin and Terlipressin on Blood Flow in Septic Shock Patients
Author Information
Author(s): Morelli A, Donati A, Ertmer C, Rehberg S, Orecchioni A, Di Russo A, Citterio G, Lombrano MR, Botticelli L, Valentini A, Pelaia P, Pietropaoli P, Westphal M
Primary Institution: University of Rome, Italy
Hypothesis
Do vasopressinergic V1 receptor agonists negatively impact microcirculatory perfusion in patients with catecholamine-dependent septic shock?
Conclusion
Vasopressin and terlipressin can reduce the need for catecholamines without harming microvascular blood flow.
Supporting Evidence
- Patients treated with AVP and TP had reduced norepinephrine requirements over time.
- No significant differences were found in mean arterial pressure or microvascular flow index between treatment groups.
Takeaway
This study shows that certain medications can help patients with severe infections need less of another medicine without causing problems with blood flow.
Methodology
60 septic shock patients were randomly assigned to receive terlipressin, vasopressin, or norepinephrine, with measurements taken at baseline and after 6 hours.
Participant Demographics
Fluid-resuscitated septic shock patients requiring norepinephrine.
Statistical Information
P-Value
P < 0.05
Confidence Interval
0.57 (0.29; 1.04) for TP and 0.40 (0.20; 1.05) for AVP
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website